Physician

Jennifer A Rein, M.D.

According to 2025 Medicare claims, Jennifer Rein, M.D. (NPI: 1376542159) practices family practice in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is HANOVER FAMILY PRACTICE ASSOCIATES, LLC (NPI: 1235197104; TIN: 232833514) and primary practice location at 17331-4321. Rein is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Rein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 298 traditional Medicare patients, billed 9,661 HCPCS/CPT codes, and received $261,186 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,156 prescription claims across 479 beneficiaries totaling $795,571 in drug costs, led by Eliquis (Apixaban). DME data shows 143 claims. Open Payments data shows 81 records totaling $1,378. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $112,644 to $261,186. Similarly, Part D prescription costs have risen steadily, from $466,210 to $795,571. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,582 and ending at $32,886.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	276	4,192	$112,644
2016	297	5,004	$149,350
2017	291	6,218	$173,487
2018	315	6,234	$172,937
2019	314	5,604	$165,442
2020	326	5,619	$163,185
2021	402	6,558	$204,561
2022	315	6,551	$207,717
2023	309	6,909	$228,066
2024	298	9,661	$261,186

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	302	6,865	$466,210
2016	319	7,384	$485,736
2017	325	7,675	$457,636
2018	337	7,139	$461,400
2019	356	6,890	$484,569
2020	401	7,313	$535,335
2021	422	6,779	$565,252
2022	440	7,281	$692,387
2023	449	7,537	$790,822
2024	479	8,156	$795,571

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	18	176	$14,628
2016	19	180	$15,319
2017	15	156	$12,375
2018	17	134	$11,852
2019	17	189	$10,129
2020	29	151	$8,655
2021	12	189	$3,385
2022	24	169	$3,893
2023	27	173	$4,603
2024	13	143	$9,159

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	265	265	$122
90673	Influenza vaccine, trivalent derived from recombinant dna	165	166	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	256	511	$76
G0008	Administration of influenza virus vaccine	167	170	$31
G0444	Annual depression screening, 5 to 15 minutes	266	266	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	96	7,142	$135,822
Ozempic	Semaglutide	36	1,960	$62,862
Soliqua 100-33	Insulin Glargine/Lixisenatide	52	1,738	$51,006
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	2,550	$50,450
Nuplazid	Pimavanserin Tartrate	12	360	$49,302

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$5,966
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	17	$1,143
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	26	$779
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$441
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	38	$420

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	81	$1,378	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jennifer A. Rein, M.D.?

Tedicare shows public-source Medicare data for Jennifer A. Rein, M.D. (NPI 1376542159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer A. Rein, M.D. have ACO affiliation data?

Jennifer A. Rein, M.D. is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Jennifer A. Rein, M.D.?

Jennifer A. Rein, M.D. is linked to HANOVER FAMILY PRACTICE ASSOCIATES, LLC (billing NPI 1235197104) in the available physician profile data.

Does Jennifer A. Rein, M.D. have Open Payments data?

Jennifer A. Rein, M.D. has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.